Fujian Cosunter Pharmaceutical Co., Ltd. announced a private placement of ordinary shares for gross proceeds of not less than CNY 948,000,000 on January 5, 2023. The transaction will include participation from no more than 35 specific investors. The transaction has been approved at the 17th meeting of the 4th board of directors and 16th meeting of 4th board of supervisors of the company, and is subject to approval at the company's general meeting of shareholders. The transaction still needs to be approved by the Shenzhen Stock Exchange and China Securities Regulatory Commission. The shares issued are restricted for trading within 6 months from the date of issuance.

On March 3, 2023, the company received acceptance for the application for issuing stocks from Shenzhen Stock Exchange.